Skip to main content

Table 1 Details of RA patients who collected synoviocytes

From: The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3

 

Sex

Age

Drug (pre-operation)

CRP (mg/dl) (pre-operation)

ESR (mm/1 h) (pre-operation)

FLS 1

Female

43

Methotrexate 10 mg/week

Prednisolone 5 mg/week

Bredinin 450 mg/day

NSAIDs

0.09

10

FLS 2

Female

56

Adalimumab 40 mg/2 week

Methotrexate 8 mg/day

NSAIDs

0.21

5

FLS 3

Female

85

Iguratimod 50 mg/day

Bucillamine 100 mg/day

1.54

91

  1. CRP C reactive protein, ESR erythrocyte sedimentation rate